OVERVIEW

Non-invasive Assessment of Clinically Significant Portal Hypertension is organized by American Association for the Study of Liver Diseases (AASLD) and will be held on Dec 12, 2022.

Description:
There is emerging data showing benefits of diagnosing clinically significant portal hypertension and its treatment to prevent decompensation. The field is rapidly evolving, specifically with respect to non-invasive modalities of measurement. This webinar will review currently available non-invasive tests to measure clinically significant portal hypertension including blood tests, liver stiffness and spleen stiffness. Use of non-invasive measurements in special populations such as those with fatty liver disease and those who have achieved sustained virological response as well as how to monitor improvements in clinically significant portal hypertension without ongoing injury are also areas of interest which will be addressed.

Additional details will be posted as soon as information is available.